MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Medtronic (NY:MDT)

87.21 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Apr 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Medtronic

< Previous 1 2 3 4 5 6 7 8 9
...
45 46 Next >
News headline image
The Teleflex Pivot: Inside the $1 Billion Share Buyback and Strategic Breakup
Disclaimer: This content is intended for informational purposes only and is not financial advice. Today’s date is April 9, 2026. Introduction In the high-stakes arena of medical technology, few stories... 
Via Finterra
Topics Economy World Trade
Medtronic PLC (NYSE:MDT): A Durable Dividend Stock for Income Investors ↗
Via Chartmill
News headline image
3 Dividend Stocks to Double Up On Right Now ↗
From energy to healthcare, this trio of reliable dividend payers are worth a deep dive today. 
Via The Motley Fool
Topics Economy
News headline image
This Healthcare Stock Has No Debt and a Near-Monopoly in Its Market ↗
The company is a picture of financial stability. 
Via The Motley Fool
Medtronic PLC (NYSE:MDT): A Dependable Dividend Stock with Strong Fundamentals ↗
Via Chartmill
News headline image
Hologic, Inc. (NASDAQ: HOLX): A New Chapter as a Women’s Health Powerhouse
Today marks a definitive turning point for Hologic, Inc. (NASDAQ: HOLX). As the company prepares to finalize its $18.3 billion acquisition by private equity giants Blackstone and TPG, it stands as a... 
Via Finterra
Topics Artificial Intelligence Retirement World Trade
News headline image
Robotic Revolution in the Electrophysiology Lab: FDA Clears Stereotaxis Synchrony System
ST. LOUIS – April 6, 2026 – In a milestone that signals a paradigm shift for cardiac care, Stereotaxis (NYSE American: STXS) has received FDA 510(k) clearance for its Synchrony™ System. The approval... 
Via MarketMinute
Topics Artificial Intelligence
News headline image
Stereotaxis Secures FDA Clearance for Synchrony™ System, Completing Its Vision for the Robotic "Digital Cockpit"
ST. LOUIS — April 6, 2026 — Stereotaxis (NYSE: STXS), a global leader in innovative robotic technologies for the treatment of cardiac arrhythmias and other endovascular procedures, announced today that... 
Via MarketMinute
News headline image
The “New BD”: A Deep-Dive Research Report on Becton, Dickinson and Company (BDX) in 2026
As of April 3, 2026, the medical technology landscape is undergoing a radical transformation, and few companies embody this evolution more than Becton, Dickinson and Company (NYSE: BDX). Known... 
Via Finterra
Topics Artificial Intelligence
News headline image
The Martha Transformation: A Deep Dive into Medtronic’s 2026 Pivot
As of April 3, 2026, Medtronic plc (NYSE: MDT) stands at a critical inflection point in its 77-year history. Once viewed as a lumbering healthcare conglomerate burdened by its own scale, the... 
Via Finterra
Topics Artificial Intelligence Initial Public Offering Product Recall
News headline image
Med-Tech Resilience: AngioDynamics Pivot Pays Off with Double-Digit Growth and Profitability
The medical technology sector has long been a bellwether for the health of the broader economy and the efficiency of the healthcare system. Today, April 2, 2026, AngioDynamics (NASDAQ:ANGO) provided... 
Via MarketMinute
Topics Economy Retirement
News headline image
The Medtronic Transformation: A Deep Dive into the Future of a MedTech Titan
As of April 1, 2026, the global medical technology landscape is undergoing a profound shift, and at the center of this evolution is Medtronic plc (NYSE: MDT). Long regarded as the "sleeping giant" of... 
Via Finterra
Topics Artificial Intelligence Economy Initial Public Offering
News headline image
The New Blue-Chip: How Johnson & Johnson Refined Its Empire for a High-Growth Future
As we enter the second quarter of 2026, Johnson & Johnson (NYSE: JNJ) stands as a starkly different entity than the consumer-facing conglomerate that defined the 20th century. Having successfully shed... 
Via Finterra
Topics Artificial Intelligence Earnings Economy
News headline image
This Dividend King Is Down 26%. When Will It Bounce Back?
Abbott Laboratories is down 26% from its 52-week high due to a soft quarter. With 54 consecutive years of dividend hikes and guidance calling for mid-single-digit organic sales growth plus 10% EPS... 
Via Barchart.com
Topics Artificial Intelligence
News headline image
Deep Dive: Boston Scientific (BSX) and the New Era of Medical Device Dominance
Date: March 31, 2026 Introduction Boston Scientific Corporation (NYSE: BSX) finds itself at a critical crossroads this morning. After a year of record-breaking growth and the successful launch of its... 
Via Finterra
Topics Lawsuit Product Recall
News headline image
Stock Market Today, March 30: Boston Scientific Falls After Delivering Underwhelming Trial Results ↗
Today, March 30, 2026, investors send Boston Scientific shares lower as they dig deeper into the company's latest trial update. 
Via The Motley Fool
Topics Stocks
News headline image
Is Intuitive Surgical a Buy Right Now? ↗
The healthcare leader has seen better times. 
Via The Motley Fool
Topics World Trade
News headline image
5 Spin-Off Stocks That Could Reward Patient Investors in 2026 ↗
Via MarketBeat
News headline image
Is Insulet Stock Underperforming the Dow?
Insulet has underperformed the Dow recently, yet analysts remain highly optimistic about the stock’s prospects. 
Via Barchart.com
Topics Stocks
News headline image
Biotech Stock Up 372% Gets Sold as New Pick Rises 40% in 2026 ↗
This clinical-stage biotech develops precision therapies for genetically defined diseases, targeting rare cancers and systemic mastocytosis. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
This Biotech Stock Has Surged 250% in a Year as One Investor Discloses $10 Million New Position ↗
This biotech firm develops targeted oncology therapies and leverages proprietary technology to address tumor resistance mechanisms. 
Via The Motley Fool
News headline image
2 Stocks That Could Create Lasting Generational Wealth ↗
These investments could help you sleep peacefully at night. 
Via The Motley Fool
Topics World Trade
News headline image
Worried the AI Hype Won't Last? These Dividend Stocks Offer Safer Exposure ↗
You don't have to go all in to profit from AI. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
How Is Zimmer Biomet Holdings’ Stock Performance Compared to Other Medical Devices Stocks?
Zimmer Biomet Holdings stock has lagged other medical device stocks over the past year, while analysts are neutral about its prospects. 
Via Barchart.com
Topics ETFs
News headline image
Economic Security First: Treasury Secretary Scott Bessent Charts a High-Stakes Course Through War and Trade
WASHINGTON D.C. — In a series of high-stakes maneuvers that have redefined the role of the U.S. Treasury, Secretary Scott Bessent has signaled a fundamental shift in American economic policy. As of... 
Via MarketMinute
Topics Artificial Intelligence Economy World Trade
News headline image
Stryker Corporation (SYK): Navigating Innovation and Resilience in the Wake of a Digital Crisis
As of March 16, 2026, the medical technology landscape is grappling with a stark reminder of the vulnerabilities inherent in the digital shift of healthcare. Stryker Corporation (NYSE: SYK), a global... 
Via Finterra
Topics Earnings Economy Hacking
News headline image
Hedge Fund Boone Capital Initiated a Stake in HealthEquity. Is the Stock a Buy? ↗
HealthEquity delivers cloud-based healthcare savings solutions to employers and individuals, with a broad client network across the U.S. 
Via The Motley Fool
News headline image
End of an Era: West Pharmaceutical Shares Slide as Longtime CEO Eric Green Announces Retirement
Shares of West Pharmaceutical Services (NYSE: WST) tumbled 5.7% on Tuesday following the announcement that Eric Green, the company’s President, Chief Executive Officer, and Chair of the Board, intends... 
Via MarketMinute
Topics Economy Retirement
News headline image
Safe Haven in a Storm: Healthcare Leads Markets as Geopolitical Tensions Spark Defensive Rotation
On a day marked by deepening global uncertainty and a sharp spike in energy costs, the healthcare sector emerged as the primary beneficiary of a massive "risk-off" migration by institutional investors.... 
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
News headline image
2 Growth Stocks to Hold for the Next Decade ↗
They are down, but they are not out. 
Via The Motley Fool
Topics World Trade
< Previous 1 2 3 4 5 6 7 8 9
...
45 46 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story